KV Sues Breckenridge Over Supplement Patent
KV and three of its subsidiaries filed the suit Thursday in U.S. District Court for the Eastern District of Missouri. The suit names Breckenridge's Folbecal and Multigen products as infringing the patents.
According to the lawsuit, KV produces two products covered by the patents at issue: PremesisRX, a vitamin supplement used to treat morning sickness in pregnant women, and Chromagen, a supplement for people with...
To view the full article, register now.